Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery

Société Française d'Anesthésie et de Réanimation3,000 enrolled

Overview

Multicenter prospective observational study, involving all adult patients who underwent cardiac surgery with extracorporeal circulation

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Cardiac Surgery Extracorporeal Circulation Fibrinogen

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient over the age of 18 that underwent a cardiac surgery with extracorporeal circulation. * Patient who agreed to participate in the study. Exclusion Criteria: * Patient under the age of 18.

Outcomes

Primary Outcomes

The international recommendations published by ESA in 2016

Review the concordance between the presence / absence of indication (according to the international recommendations published by ESA in 2016) and the prescription / non-prescription of fibrinogen concentrates

Time frame: 13 Months

Central Contacts

Longrois Dan, Pr

CONTACT

dan.longrois@aphp.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.